Literature DB >> 10487707

Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter.

E M Gabriel1, E R Bergert, C S Grant, J A van Heerden, G B Thompson, J C Morris.   

Abstract

Toxic multinodular goiter (TMNG) represents a frequent cause of endogenous hyperthyroidism, affecting 5-15% of such patients (with higher frequencies reported in iodine-deficient areas of the world). Although mutations of human TSH receptor (hTSHR) have been described in autonomously functioning thyroid nodules (AFTN), the role of such mutations in the pathogenesis of TMNG remains unclear. To search for alterations of hTSHR in AFTN and TMNG, we performed bidirectional, dye primer automated fluorescent DNA sequencing of the entire transmembrane domain and cytoplasmic tail of hTSHR (TMD+CT-hTSHR) using DNA extracted from nodular regions of 24 patients with TMNG and 7 patients with AFTN. Eight of the 24 patients (33.3%) showed heterozygote polymorphism of codon 727 on the cytoplasmic tail of hTSHR with an amino acid substitution of aspartic acid to glutamic acid. Three of 24 (12.5%) patients with TMNG were found to carry a heterozygote mutation of codon 703, resulting in substitution of alanine with glycine. One patient had multiple heterozygote mutations including I606M (Ile to Met), A703G (Ala to Gly), Q720E (Gln to Glu), and D727E (Asp to Glu). Two patients exhibited silent polymorphism of codons 460 and 618. We found no mutation of the TMD+CT-hTSHR in 7 patients with AFTN, except for a silent polymorphism of codon 460 in 1. DNA fingerprinting of codon 727 using restriction enzyme NlaIII and genomic DNA confirmed the sequencing results in all cases, indicating that the sequence alterations were not somatic in nature. This technique was also used to examine peripheral blood genomic DNA from 52 normal individuals and 49 patients with Graves' disease; 33.3% of TMNG (P = 0.019 vs. normal subjects), 16.3% of Graves' disease patients (P = 0.10 vs. normal subjects), and 9.6% of normal individuals were heterozygous for the D727E polymorphism. Expression of the D727E hTSHR variant in eukaryotic cells (COS-7) resulted in an exaggerated cAMP response to TSH stimulation compared to that of the wild-type hTSHR. These findings indicate that a germline polymorphism of codon D727E of hTSHR is associated with TMNG, suggesting that its presence is an important predisposing genetic factor in the pathogenesis of TMNG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487707     DOI: 10.1210/jcem.84.9.5966

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  The rs1991517 polymorphism is a genetic risk factor for congenital hypothyroidism.

Authors:  Yedukondalu Kollati; Radha Rama Devi Akella; Shaik Mohammad Naushad; Maunika Thalla; G Bhanuprakash Reddy; Vijaya R Dirisala
Journal:  3 Biotech       Date:  2020-06-01       Impact factor: 2.406

3.  RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.

Authors:  A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

4.  Comparison of surgical techniques for treatment of benign toxic multinodular goiter.

Authors:  Orhan Alimoglu; Murat Akdag; Mustafa Sahin; Cagatay Korkut; Ismail Okan; Neslihan Kurtulmus
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population.

Authors:  Teresa Manuela Vicchio; Salvatore Giovinazzo; Rosaria Certo; Mariapaola Cucinotta; Carmelo Micali; Sergio Baldari; Salvatore Benvenga; Francesco Trimarchi; Alfredo Campennì; Rosaria Maddalena Ruggeri
Journal:  J Endocrinol Invest       Date:  2014-05-01       Impact factor: 4.256

6.  TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.

Authors:  N E Bufalo; R B Dos Santos; M A Marcello; R P Piai; R Secolin; J H Romaldini; L S Ward
Journal:  J Endocrinol Invest       Date:  2014-12-28       Impact factor: 4.256

7.  Polymorphisms in TSHR gene and the risk and prognosis of autoimmune thyroid disease in Tunisian population.

Authors:  I Zaaber; S Mestiri; H Marmouch; B Bel Hadj Jrad Tensaout
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

8.  Hyperfunctioning Papillary Thyroid Carcinoma with a BRAF Mutation: The First Case Report and a Literature Review.

Authors:  Shinsuke Shinkai; Kenji Ohba; Kennichi Kakudo; Takayuki Iwaki; Yoshihiro Mimura; Akio Matsushita; Go Kuroda; Yuki Sakai; Nobuhiko Nishino; Kazuo Umemura; Takafumi Suda; Shigekazu Sasaki
Journal:  Eur Thyroid J       Date:  2021-03-05

9.  The Glu727 Allele of Thyroid Stimulating Hormone Receptor Gene is Associated with Osteoporosis.

Authors:  Ren-De Liu; Rui-Xiong Chen; Wen-Rui Li; Yu-Liang Huang; Wen-Hu Li; Guang-Rong Cai; Heng Zhang
Journal:  N Am J Med Sci       Date:  2012-07

10.  Clinical significance of heterozygous carriers associated with compensated hypothyroidism in R450H, a common inactivating mutation of the thyrotropin receptor gene in Japanese.

Authors:  Keisuke Kanda; Haruo Mizuno; Yukari Sugiyama; Hiroki Imamine; Hajime Togari; Kazumichi Onigata
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.